Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.76 USD
-0.09 (-2.99%)
Updated Sep 10, 2024 03:59 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Arcadia Biosciences (RKDA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.00 | $6.00 | $6.00 | 110.53% |
Price Target
Only one analyst offered a short-term price target of $6.00 for Arcadia Biosciences. This represents an increase of 110.53% from the last closing price of $2.85.
Analyst Price Targets (1 )
Broker Rating
Arcadia Biosciences currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/RKDA.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/21/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
5/14/2024 | Lake Street Capital Markets | Benjamin D Klieve | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $6.00 |
LT Growth Rate | NA |
Industry | Agriculture - Products |
Industry Rank by ABR | 202 of 253 |
Current Quarter EPS Est: | -0.77 |
RKDA FAQs
Arcadia Biosciences, Inc. (RKDA) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Arcadia Biosciences, Inc. (RKDA) is $6.00. The current on short-term price targets is based on 1 reports.
The forecasts for Arcadia Biosciences, Inc. (RKDA) range from a low of $6 to a high of $6. The average price target represents a increase of $110.53 from the last closing price of $2.85.
The current UPSIDE for Arcadia Biosciences, Inc. (RKDA) is 110.53%
Only one analyst offered a short-term price target of $6.00 for Arcadia Biosciences. This represents an increase of 110.53% from the last closing price of $2.85.